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Abstract
Background: The gut microbiota is playing more important roles in host immune regulation than was initially
expected. Since many benefits of microbes are highly strain-specific and their mechanistic details remain largely
elusive, further identification of new probiotic bacteria with immunoregulatory potentials is of great interest.
Results: We have screened our collection of probiotic lactic acid bacteria (LAB) for their efficacy in modulating host
immune response. Some LAB are characterized by suppression of TNF-α induction when LAB culture supernatants
are added to THP-1 cells, demonstrating the LAB’s anti-inflammatory potential. These suppressive materials were
not inactivated by heat or trypsin. On the other hand, treatment of THP-1 directly with live bacterial cells identified
a group of pro-inflammatory LAB, which stimulated significant production of TNF-α. Among those, we chose the
Lactobacillus reuteri BM36301 as an anti-inflammatory strain and the L. reuteri BM36304 as a pro-inflammatory strain,
and further studied their in vivo effects. We supplied C57BL/6 mice with these bacteria in drinking water while feeding
them a standard diet for 20 weeks. Interestingly, these L. reuteri strains evoked different consequences depending on
the gender of the mice. That is, males treated with anti-inflammatory BM36301 experienced less weight gain and
higher testosterone level; females treated with BM36301 maintained lower serum TNF-α as well as healthy skin with
active folliculogenesis and hair growth. Furthermore, while males treated with pro-inflammatory BM36304 developed
higher serum levels of TNF-α and insulin, in contrast females did not experience such effects from this bacteria strain.
Conclusion: The L. reuteri BM36301 was selected as an anti-inflammatory strain in vitro. It helped mice maintain healthy
conditions as they aged. These findings propose the L. reuteri BM36301 as a potential probiotic strain to improve various
aspects of aging issues.
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Background
The collections of commensal microbes, called microbiota,
are superior to their host in number as well as in genetic
and metabolic diversity [1]. Particularly the gut microflora,
which comprises more than 90 % of all commensals, have
profound effects on their host in the development and
maintenance of body systems, including metabolism, im-
mune regulation, or even neuronal function [1, 2]. There
are an increasing number of reports suggesting that a dis-
ruption in the normal composition of microbial communi-
ties can cause a wide array of health issues [3–7]. These
include obesity, diabetes, metabolic syndrome, inflamma-
tory bowel disease (IBD), autoimmune disease, colon can-
cer, or even depression and neurodevelopmental disorders
[3, 4, 8–10]. Intriguingly, oral supplementation of selective
bacteria to individuals suffering from health problems has
shown to be effective in ameliorating the symptoms or
curing the disease, in part by rebalancing the gut microbial
composition [8, 9, 11, 12]. As a result, these beneficial
microbes (or probiotics) and their metabolites have come
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under great interest with respect to their therapeutic
potential. Accordingly, lactic acid bacteria (LAB), which
have been widely used in food processing for a century,
are now under re-evaluation in regard to their probiotic
efficacy [6, 11, 13].
In order for dietary probiotics to effectively function in
the gut, they should meet certain basic qualifications
[14–17]. First, they must be able to withstand the chal-
lenging environment of gastric acids, digestive enzymes,
or bile salts in the stomach and intestines. Also, their
intrinsic antimicrobial activities against pathogens would
be beneficial to hosts. Finally, it is desirable that they
can adhere well enough to the mucosal layer in the
gastrointestinal (GI) tract, especially since they need to
compete with other pathogens for nutrient uptake.
Probiotics contain not only these general health advan-
tages but also other far more diverse benefits. In particu-
lar, the involvement of gut microbes in the regulation of
host immune function is extraordinarily comprehensive
[1, 11, 13, 18–20]. Many studies have used germ-free or
antibiotic-treated mice to compare the susceptibility of
developing immune disease with that of conventionally
grown or non-treated mice, respectively. The current
understanding of the roles of gut microbes in host
immune regulation can be briefly summarized as follows.
First, the gut flora contributes to the development of
various lymphoid cells, including TH17 cells, TReg Cells,
IgA-producing plasma cells, and innate lymphoid cells.
Second, it confers resistance against pathogenic bacteria
or viruses by enhancing innate and adaptive immunities.
Third, the gut flora influences development of intestinal
disease. For example, IBD can be stimulated by unprece-
dented overgrowth of pathogenic symbionts. In this case,
the homeostasis between beneficial bacteria and patho-
gens are critical to minimize the inflammatory shift.
Finally, the gut flora has the capacity to affect even
extra-intestinal diseases, such as multiple sclerosis, arth-
ritis, type 1 diabetes, allergic inflammation, and cancers
[18, 19]. These systemic effects even extend to affect
skin health, skin wound healing, eczema, and endocrine
pathways predominantly via immune networks [21, 22].
Local interactions between the gut microbiota and its
host primarily involve the direct recognition of bacterial
surface molecules by neighboring epithelial cells and
immune cells in the intestine [13, 18]. For example, lipo-
polysaccharide (LPS), peptidoglycan, lipoteichoic acids,
and exopolysaccharides of certain bacterial cell walls can
induce a variety of gut immune responses. Expression and
modification of these compartments depend on bacterial
genes and metabolic activities, which explains the strain-
specificity. Meanwhile, remote interactions can be initi-
ated by secretion of various bacterial metabolic products
[13]. For example, organic acids such as L-lactic acid
(from Lactobacillus casei strain Shirota) and short-chain
fatty acids (SCFAs) (from various gut bacteria), poly-
amines (from Bifidobacterium animalis subsp. lactis strain
LKM512), small metabolites such as AI-3 (from com-
mensal E. coli) and histamine (from L. reuteri strain ATCC
PTA 6475), or even proteins such as p40/p75 (from Lacto-
bacillus rhamnosus strain GG) were reported for their
remote immunoregulatory roles [23–27].
As an effort to search for immunomodulatory microbes,
in vitro tissue cultures using myeloid cells such as THP-1,
peripheral blood mononuclear cells (PBMCs), dendritic
cells (DCs), or intestinal epithelial cells (IECs) have been
widely employed [28]. Common cytokines studied include
tumor necrosis factor α (TNF-α), interleukins 8, 12, and 17
(IL-8, IL-12, and IL-17), all of which are known to induce
many inflammatory responses, primarily pro-inflammatory.
In contrast, transforming growth factor β (TGF-β) and IL-
10 are frequently assessed as anti-inflammatory markers.
For example, culture supernatants from various LAB were
shown to contain metabolites that suppress the expression
of TNF-α or enhance the expression of IL-10 in various
in vitro tissue culture systems [29, 30]. Also, direct treat-
ment of immune cells with live bacteria resulted in the
secretion of various cytokines [31]. These studies have
established in vitro approaches to identify immunoregula-
tory microbes and metabolites [13].
Since these regulatory functions of LAB are highly
strain-specific, great potential for further characterization
of LAB remains. In this study, we established a protocol to
isolate probiotic LAB with potential immunoregulatory
ability. We compared both anti-inflammatory and pro-
inflammatory activities of each bacterial strain in vitro.
Finally, we applied the elected LAB to a mouse model sys-
tem to verify their relevance with respect to the in vitro
screening.
Results
Characterization of probiotic lactic acid bacteria
We have been isolating lactic acid bacteria (LAB) for
years from various sources including humans, animals,
plants, and food products. These Benebios Microorgan-
isms (BM) collections are comprised of over 500 strains,
with probiotic potentials revealed from their initial
screenings. In this study, we chose four human com-
mensal strains derived from fecal samples and further
studied them in detail (Table 1). Those specifically ex-
amined were two Lactobacillus reuteri strains (BM36301
and BM36304), a L. gasseri strain (BM33601), and a Bifi-
dobacterium animalis subsp. lactis strain (BM10307).
We examined the bacteria with respect to their general
qualifications as probiotics (Table 1). First, these BM
strains showed resistance against acids (pH 2.5) and bile
salts (0.3 %), demonstrating a 43 % to 98.5 % survival rate
range after 1 h treatment at 37 °C, which are reasonably
high scores [14]. Next, we tested the antimicrobial activities
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against enteric bacteria. While L. gasseri BM33601 showed
a minimal inhibition of the tester strain E. coli, all others
formed distinct inhibitory zones (0.5–3 mm distance from
LAB edges). These inhibitory effects are usually caused by
bacteriocins, organic acids (lactic acid or acetic acid),
hydrogen peroxide, or ethanol from the LAB [32, 33].
Finally, we looked at their ability to bind to human intes-
tinal epithelial cells (IECs) in vitro. For this purpose, we
cultivated human colon cancer cells, HT-29, on coverslips
for 15 days and applied live LAB cultures onto them for
1 h (Methods). After extensive washing, the remaining
bacterial cells were visualized by Gram staining for count-
ing under the microscope [34]. The L. reuteri strains
BM36301 and BM36304 showed high retention scores
(5.5–7.4 bacteria per HT-29), while L. gasseri BM33601
had moderate (1.7 bacteria per HT-29) and B. animalis
subsp. lactis BM10307 had low (0.3 bacteria per HT-29)
scores. Stronger adhesion of LAB to IECs is particularly
important since they need to stay at the gut mucosal layer
long enough for the benefits to take effect on the host
[16, 17, 34]. From these primary experiments, the two
L. reuteri strains revealed higher potential as quality
probiotics.
Regulation of TNF-α production by lactic acid bacteria
in vitro
We aimed to screen LAB for their potential to suppress
intestinal inflammation. To this end, we adapted an in
vitro tissue culture system where the human myeloid cells
(THP-1) secrete TNF-α upon activation of their Toll-
like receptors (TLR) by bacterial lipopolysaccharide (LPS)
[28, 29]. First, we verified that THP-1 cells of 5 × 104 in
1 ml culture treated with LPS at 150 ng/ml dosage for
3.5 h usually resulted in a production of 200–300 pg/ml
TNF-α (Fig. 1a, lanes 1 and 2). Next, we collected the su-
pernatants of bacterial cultures grown for 24 h, vacuum-
dried them, and reconstituted the conditioned medium
(CM) (Methods). This CM contains complex activities to
both suppress and induce TNF-α, depending on the LAB
and culture conditions [23, 29]. Indeed, we observed slight
production of TNF-α by the CMs from BM36304 and
BM36301 without LPS, but this amount was less than
20 % of LPS-stimulated induction (data not shown). Fi-
nally, we added each CM up to 5 % of THP-1 culture (v/v)
in the presence of LPS (Fig. 1a, lanes 3–6). The TNF-α
production with LPS (208 ± 49 pg/ml, lane 2) was sup-
pressed to 40 % with the CM from L. reuteri BM36301
(90.90 ± 49.3 pg/ml, lane 3), and to 52 % with the CM
from B. animalis subsp. lactis BM10307 (118.8 ± 19.0 pg/
ml, lane 6). For our screening purposes, we considered the
suppression of TNF-α close to or less than 50 % of expres-
sion by LPS treatment as anti-inflammatory. However, the
CMs from L. reuteri BM36304 and L. gasseri BM33601
were not able to suppress the TNF-α production to that
point. We verified this inert activity by preparing these
CMs under various culture conditions (data not shown).
Next, we examined the TNF-α induction capacity of the
bacterial cells themselves because cellular components of
the Gram positive bacteria may induce inflammatory re-
sponses [13, 31]. For this purpose, we grew bacteria to an
exponential phase (16 h), then harvested, washed, and
added these live bacterial cells in excess (250-fold cell
counts) to the THP-1 culture. Metabolic activities of bac-
terial cells were kept minimized by antibiotics added in
the THP-1 medium. After 6 h of incubation, the secreted
TNF-α was quantitatively measured (Fig. 1b). Even though
all four LAB cells were found to induce TNF-α, BM36301
produced significantly smaller amount (609 pg/ml) than
the others: BM36304 (2342 pg/ml), BM33601 (3100 pg/ml),
and BM10307 (7141 pg/ml). During this 6-hr co-incubation,
we observed that THP-1 cells experienced variable cell
death depending on the LAB used (Additional file 1).
Most notably, BM36301, the lowest TNF-α inducer,
caused the least amount of THP-1 death (9.7 %), while the
other higher TNF-α inducing strains caused significantly
more prominent death (24–38 %). Therefore, it is not the
case that BM36301 induced low TNF-α due to the loss of
THP-1 viability per se. For our screening purposes, we
considered LAB with active TNF-α production of more
than 1000 pg/ml as pro-inflammatory.
In summary, the in vitro immunomodulation activities
were assigned as anti-inflammatory with the suppressive
Table 1 Characterization of Probiotic Lactic Acid Bacteria
Strain Taxonomy Resistance against a Antimicrobial activityb Adhesion to IECc
Acids (pH 2.5) Bile salts (0.3 %)
BM36301 L. reuteri 50.2 % 53.4 % + 5.5 ± 0.4
BM36304 L. reuteri 83.5 % 89.4 % ++ 7.4 ± 0.8
BM33601 L. gasseri 98.5 % 72.6 % ± 1.7 ± 0.2
BM10307 B. animalis subsp. lactis 43.0 % 47.3 % + 0.3 ± 0.05
aThe survival rate was calculated by comparing the colony forming unit (CFU) of treated culture with that of untreated control. A representative data from more
than three independent experiments is shown
bClear zonal inhibition of the growth of the tester strain was measured from the edge of the spot (see Methods) and expressed as; ± (less than 0.5 mm inhibitory
zone), + (0.5 ~ 1.0 mm), or ++ (1.0 ~ 3.0 mm)
cAverage bacterial count per HT-29 cells is listed with standard deviation (± SD)
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CM (BM36301 and BM10307) and pro-inflammatory
with the inductive live cells (BM36304, BM33601, and
BM10307). Since BM10307 showed both activities, we
assigned it as possessing dual functionality (Fig. 1c). It
was interesting to note that the two L. reuteri strains dis-
played distinct activities. From the initial screening of
our wide range of BM collections, the anti-inflammatory
strains proved to be rather rare, with a discovery rate of
less than 5 % (data not shown). Also some strains
showed neither activity, thus falling into the category of
‘neutral’ (data not shown).
Suppressive molecules in the CMs are stable against heat
and trypsin
Since the CM from LAB is composed of various bacter-
ial metabolites as well as cellular components, we sought
to better understand the anti-inflammatory nature of the
CM. The expression of TNF-α quantitatively diminished
with increasing concentrations of the CMs from L. reu-
teri BM36301 (Fig. 2a) and B. animalis subsp. lactis
BM10307 (Fig. 2b). Interestingly, a smaller amount of
CM from BM36301 (0.5× input or 2.5 % v/v) actually
induced TNF-α further, consistent with the observation
that this CM contains TNF-α-inducing materials to some
extent (Fig. 2a, lanes 2 and 3). Nonetheless, the suppressive
effects became dominant in the face of higher amounts of
CM, suggesting that the anti-inflammatory materials are
quantitatively additive and that the corresponding recep-
tors on the THP-1 cell surface are abundant enough to
readily respond to increasing CM treatment. Overall, these
observations suggest that the CMs contain active metabo-
lites responsible for TNF-α suppression, in spite of their
complex nature.
We further examined the physicochemical characteris-
tics of anti-inflammatory materials in the CMs. Boiling
the CMs from each strain for 10 min was found to be
ineffective in altering their TNF-α inhibitory functions
compared with native CMs (Fig. 2c, lanes 3 and 4). Like-
wise, trypsin treatment did not affect their activities
(Fig. 2c, lane 5). These observations suggest that the
main inhibitory factors in these CMs are neither pro-
teins nor heat-sensitive molecules.
Regulation of TNF-α in mice with probiotic bacteria
The ultimate question in regard to in vitro TNF-α regu-
lation based on our LAB screening was how relevant it
would be with the in vivo applications. We directly
sought to answer this question by applying the selected
L. reuteri strains to a mouse model system. We prepared
20-week-old, inbred C57BL/6 mice of 6 males and 8
females per group. Then over a 20-week period, one
group was treated with the anti-inflammatory BM36301,
another group was treated with the pro-inflammatory
BM36304, and the control group was treated with
dextrose (Methods). As a means to minimize distress on
the animals, the LAB cultures were administered via
drinking water to meet the daily consumption dosage of
1 × 106 bacteria per mouse. We also provided a standard
diet so that the aging process was natural during the
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Fig. 1 Immunomodulation by lactic acid bacteria in vitro. a Screening
of lactic acid bacteria (LAB) with conditioned medium (CM) for anti-
inflammatory activities against LPS-induced TNF-α production in THP-1.
Without LPS, a non-detectable amount of TNF-α was observed (lane 1).
With 150 ng/ml of LPS treatment, THP-1 cells produced significant
amounts of TNF-α (lane 2). Each CM was treated to 5 % of the THP-1
culture volume to assess its inhibitory effects (lane 3, L. reuteri
BM36301; lane 4, L. reuteri BM36304; lane 5, L. gasseri BM33601; and
lane 6, B. animalis subsp. lactis BM10307). CM from control medium
(MRS) was prepared and added in lanes 1 and 2. * indicates p < 0.03
from the t-test between the control (lane 2) and either BM36301 CM-
treated (lane 3) or BM10307 CM-treated (lane 6). Bars show averages
with standard deviation (SD) from 5 independent assays. b Screening
of LAB with live cells for pro-inflammatory activities to induce TNF-α
production in THP-1 cells. About 1.5 × 108 bacterial cells from
exponentially growing cultures were applied to 6 × 105 THP-1 cells
for 6 h. The cell-free supernatants were collected and assessed for
the secreted TNF-α by ELISA method. The results show averages
with SD from 4 independent experiments. c Summary of in vitro
immunomodulation by various lactic acid bacteria
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40 weeks old age), we euthanized the mice and withdrew
blood for serum preparation to measure cytokines and
testosterone using quantitative ELISA methods. Upon
performing necropsy, we found no gross morphologic
abnormalities.
We were primarily interested in the serum TNF-α levels
from these mice. As shown in Fig. 3a, control males
showed 5.85 ± 1.34 pg/ml of serum TNF-α. BM36301-
treated males showed a slight reduction (4.90 ± 0.9 pg/ml),
though without meaningful significance (p = 0.59). How-
ever, BM36304-treated males maintained significantly
higher TNF-α levels (8.28 ± 1.09 pg/ml, p = 0.006 vs. con-
trol). We also quantitated the female’s TNF-α concentra-
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Fig. 2 Suppressive CMs are quantitative and resistant against heat and enzymatic digestion. a CM from L. reuteri strain BM36301 represses TNF-α
production from LPS-treated THP-1 cells in a quantitative manner. TNF-α levels produced from the THP-1 cultures with (lanes 2 – 6) or without
(lane 1) LPS were measured by ELISA method. For treatment of CM, 2.5 % (0.5×, lane 3), 5 % (1×, lane 4), 10 % (2×, lane 5), or 15 % (3×, lane 6) of
THP-1 culture volume (v/v) was added at the time of LPS stimulation. CM from the control medium (MRS) was added to 5 % in lanes 1 and 2. The data
show averages with SD from 3 independent assays. b CM from B. animalis subsp. lactis strain BM10307 contains metabolites that repress TNF-α production
from LPS-treated THP-1 cells in a quantitative manner. The LPS and CM were treated as indicated. CM from the control medium (BL) was added to 5 % in
lanes 1 and 2. Data are from 3 independent experiments. c CMs from BM36301 (gray) or BM10307 (black) were either boiled (lane 4) or treated with trypsin
(lane 5) to compare their activities with native CMs (lane 3). Results are averages with SD from 3 independent experiments
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retained higher TNF-α levels (7.9 ± 1.05 pg/ml) than the
male control group, though without significance (p = 0.42).
Most notably, BM36301-fed females displayed significantly
reduced amounts of TNF-α (5.17 ± 0.80 pg/ml, p = 0.017
vs. control), while BM36304-treated females showed simi-
lar levels with the control mice (7.43 ± 2.69 pg/ml, p = 0.71
vs. control). Unlike these variations of TNF-α, we could
not discern meaningful differences of serum IL-10 levels
between the groups (data not shown).
In summary, we observed a reduction of serum TNF-α
with the anti-inflammatory BM36301, with a more pro-
nounced effect observed in females. The pro-inflammatory
BM36304 led to an increase of TNF-α in males, but not in
females. These findings suggest that our in vitro screening
carries meaningful relevance with in vivo maintenance of
TNF-α in these mouse trials.
L. reuteri BM36301 maintained reduced body weight gain
and high testosterone in male mice
Aging is the source of many health issues in humans,
including diabetes and obesity. In order to exacerbate
such aging issues in the animal model, high fat diets are
often employed [35, 36]. However, the interpretation on
those accelerated experiments can be complicated since
no aging in humans should be driven by a purposed high
fat diet. We cultivated all the mice with a standard diet
so that their aging process could be most natural. In the
20-week experiment timespan starting from the age of
20 weeks old, control group males gained about 8 g
weight (7.83 ± 1.2 g) and control group females gained
about 5 g weight (4.8 ± 0.94 g). Remarkably, it was
noticeable that the weight gain in males fed with the
anti-inflammatory BM36301 was significantly lower than
in the control (5.78 ± 0.75 g, p = 0.040) by 36 % (Fig. 4a,
lanes 1 and 2). However, the weight gain of BM36304-
treated males (7.53 ± 0.74 g) was not significantly differ-
ent from the control (p = 0.67). The weight gains of the
female groups were not statistically different from each
other.
Another significant difference was the serum insulin
level from BM36304-treated males (Fig. 4b). While the
control male group showed 3.18 ± 0.65 ng/ml of insulin,
the BM36304-fed male group showed 4.91 ± 0.63 ng/ml of
insulin (p = 0.027). However, consistent with the finding
that the weight gain from this group was not much differ-
ent from the control (Fig. 4a), we did not observe a more
prominent abdominal fat accumulation in BM36304-
treated males (data not shown). At 40 weeks old, the insu-
lin spike may not have caused clinically-evident diabetes
in the mice, but the disease may have become more pro-
nounced if the mice aged further. The insulin variation
between the female groups was not significantly different
from each other.
Finally, we focused on the males’ testosterone levels. As
shown in Fig. 4c, the anti-inflammatory BM36301-fed
males retained significantly higher levels of serum testos-
terone (5.18 ± 0.87 ng/ml) than the control group (2.20 ±
0.38 ng/ml, p = 0.0025). However, the BM36304-treated
group was not statistically different (3.23 ± 2.10 ng/ml,
p = 0.07) from the control. In order to further under-
stand the testosterone results, we examined the testicles
of each mouse. The weight of paired testes of the
BM36301-fed males was 0.579 ± 0.075 g, 10 % heavier
than that of the control’s (0.525 ± 0.05 g, p = 0.049).
Considering the smaller weight gain in the BM36301
group (Fig. 4a), this size difference of the testes is more
evident; the ratio of testes-weight to body-weight-gain
(TW/WG) of the control was only 67 % of that of the
BM36301 group. However, we could not observe micro-
scopic differences of the tissues from the testes, such as















































Fig. 3 TNF-α from mice C57BL/6 supplemented with probiotic bacteria.
a The TNF-α of the serum from male mice (n = 6 each) each fed with L.
reuteri strain. ** indicates p= 0.006 from the t-test in comparison with the
control group (lanes 1 and 3). b The TNF-α of the serum from female
mice (n = 8 each) each fed with L. reuteri strain. * indicates p= 0.017 from
the t-test in comparison with the control group (lanes 1 and 2)
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groups (156.03 ± 6.65 μm of control vs. 153.95 ± 18.66 μm
of BM36301-treated males, p = 0.51). We have not per-
formed other studies such as comparing spermatogenesis
or Leydig cell area.
In summary, the anti-inflammatory BM36301 helped
males maintain lower weight gain with bigger testes and
more testosterone as they aged. Reduced testosterone
production in aged males has been proposed to be
related with age-dependent lesions in the testes, presum-
ably as a result of inflammatory insult [36, 37]. Meanwhile,
the pro-inflammatory BM36304 triggered an increase of
insulin, though without changes in weight gain or testos-
terone among males. Notably, none of these bacterial
strains had meaningful influences on these body measures
in female mice.
Healthy female skin from anti-inflammatory BM36301
One interesting feature of certain probiotics is that they
can promote skin health in a manner dependent on im-
mune regulation [21, 38]. Since the BM36301 also showed
anti-inflammatory effects in vitro and in vivo, we asked
the question whether this strain can provoke such health
benefits in skin. At the 18th week of treatment, we shaved
an area on 2 mice from each group and examined them
after 1 week. Interestingly, BM36301-fed female mice ex-
hibited faster hair re-growth, though not full recovery, at
the shaved area (Fig. 5a). In contrast, control or BM36304
groups did not display such a rapid pace of recovery. None
of the treated males showed hair re-growth distinguishably
faster than the control, indicating that this accelerated hair
growth may be obvious in only females. Another metric to
evaluate skin health is by examining fur shininess. How-
ever, we did not observe meaningful differences between
each group through sensory or light meter measurements,
mainly due to the relatively shiny fur conditions of the
controls (data not shown).
We further assessed skin health by examining skin
cross-sections under the microscope after staining with
Hematoxylin and Eosin. As shown in Fig. 5b and c, we
found that the BM36301-treated female mice showed
higher counts of subcutaneous hair follicle (HF) than con-
trol female mice. The HF counts per microscopic view at
400× resolution were 3.50 ± 0.52 for the control female
group, while the counts were 4.80 ± 0.61 from BM36301-
fed females with a meaningful difference (p = 0.023). How-
ever, BM36304-treated females presented only a slight
change (4.15 ± 1.73, p = 0.55 vs. control). Upon a more
detailed analysis of the hair follicles, we found that the
BM36301-fed females displayed marginally more active
hair cycle stages than the control (anagen + catagen: telo-
gen was 81:19 from control vs. 95: 5 from BM36301-fed
females). Meanwhile, the HF counts from the male groups
were not much different from each other (Fig. 5b). Finally,
we also assessed the skin thickness measured as the depth
from the epidermis to panniculus carnosus (Fig. 5c,
Additional file 1). We could not find much difference of
the depth between the control and the BM36301-treated
females. However, the dermal layers of BM36301-fed
mice proved marginally deeper than the controls’, and
the adipose tissue from BM36301-treated mice was
shallower than that that of the control. Most of the









































































Fig. 4 Aged male mice supplemented with L. reuteri strain BM36301
maintain healthy body index. a Net weight gain of mice C57BL/6
(n = 6 for male, grey bar; n = 8 for female, dark bar) fed with each
L. reuteri strain for 20 week period. * indicates p = 0.040 from the
t-test in comparison with the control group (male lanes 1 and 2).
b Serum insulin concentration from mice fed with each L. reuteri
strain as in (a). ** indicates p = 0.027 from the t-test in comparison
with the control group (male lanes 1 and 3). c Serum testosterone
amount from male mice fed with each L. reuteri strain as in (a). ***
indicates p = 0.0025 from the t-test in comparison with the control
group (lanes 1 and 2)
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Overall, these observations suggest that the treatment
with anti-inflammatory BM36301 fostered healthier skin
as evidenced by hair re-growth and HF counts in females.
However, the microscopic differences of skin samples
between the control and the BM36301 groups appeared
rather marginal. These skin health benefits were not
observed in males. Also, the pro-inflammatory BM36304
did not cause any adverse effects on the skin at the time
of experiments.
Discussion
In this study, we have examined the health benefits of
the L. reuteri BM36301 strain. This strain met selection
criteria for further in vitro and in vivo studies (Table 1).
From an anaerobic cultivation, this strain produced a
culture supernatant containing various metabolites and
cellular components, which could inhibit TNF-α produc-
tion in the LPS-activated THP-1 assay. Furthermore, this









































Fig. 5 Aged female mice supplemented with L. reuteri strain BM36301 display healthy skins. a Hair re-growth experiment on C57BL/6 mice consuming L.
reuteri strain-treated water or control water. A 2 × 2 cm wide area of skin was clearly shaved and the hair re-growth was examined a week later. b Hair
follicle (HF) counts were collected from the skin section samples of mice fed with either control or L. reuteri strains. Five microscopic images at 400×
resolution from 5 to 8 mice were counted. * indicates p = 0.023 from the t-test in comparison with the control group (female lanes 1 and 2). c Skin
sections from control (left) and BM36301-treated (right) mice were stained with Hematoxylin and Eosin to show skin tissue layers and HFs as labeled.
Photos were taken at 100× resolution; the bar indicates of 100 μm in length for scale
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contact with the THP-1 cells, suggesting that it may be
less inflammatory by itself in the gut (Figs. 1 and 2).
Taken together, we postulated that BM36301 is an anti-
inflammatory probiotic. In order to evaluate the in vivo
effects of the strain, we examined various body measures
of the mice that had been fed with this strain in drinking
water. During the natural aging process, the treatment
with L. reuteri BM36301 helped the male mice maintain
reduced weight gain by 36 % less than the control mice
(Fig. 4). Also, this L. reuteri treatment resulted in males
with heavier testicles and significantly higher serum tes-
tosterone levels. BM36301-fed female mice were found
to have significantly lower levels of serum TNF-α than
the control (Fig. 3). In addition, females consuming this
strain displayed healthier skin with active folliculogenesis
and faster hair growth (Fig. 5).
Identification of the anti-inflammatory metabolites from
probiotic strains is being actively pursued due to their
pharmaceutical effects. More recently, it was shown that
histamine metabolically secreted into culture media from
the human-commensal, L. reuteri ATCC PTA 6475, could
effectively suppress a TLR pathway in vitro, which is in-
volved in the TNF-α stimulation by LPS [23, 39]. This
strain turned out to be an effective probiotic from in vivo
trials with experimental models in regard to colitis, IBD,
obesity, aging, and skin health [36, 38, 40, 41]. In our
study, the components responsible for TNF-α suppression
from the BM36301 in CM appeared to be heat-stable,
non-protein molecules (Fig. 2). It is of future interest to
isolate these molecules and further analyze their biochem-
ical properties. It would also be ultimately important to
identify their biological activities related with the various
health benefits we have discovered in this study.
Unlike BM36301, another L. reuteri strain BM36304
did not produce such an anti-inflammatory CM under
our experimental conditions. Instead, BM36304 cells
stimulated THP-1 to produce TNF-α in vitro (Fig. 1), in-
dicating an example of strain-specificity. However, this
does not mean that BM36304 is pro-inflammatory de
facto, since it is not yet clearly understood how a strain
can drive immune regulations into diverse directions.
For example, the L. reuteri strain DSM 17938, which
demonstrated pro-inflammatory effects in vitro, has been
previously reported for its overall anti-inflammatory ef-
fects from in vivo animal models of necrotizing entero-
colitis [42]. Indeed, we have not examined the effects of
BM36304 on IECs, which are actual cells in the lumen
surface. Furthermore, we have not observed adverse
clinical effects in mice treated with this bacteria. We
may need to assess other indexes such as blood sugar or
skin dermatitis scores from a BM36304-treated model
for further clarification.
The probiotic benefits of BM36301 manifested differently
depending on the host gender. Recent studies performed
with male mice suggest that age-associated testicular atro-
phy is mostly due to the pro-inflammatory activation of the
immune system, including TH17 lymphocytes [36]. There-
fore, it seems likely that the anti-inflammatory network in
the BM36301-fed males protected their testicle size and tes-
tosterone levels from atrophy as they aged, while the testes
of untreated males displayed pro-inflammatory deterior-
ation. Since testosterone is important for the conservation
of youthful, healthy bodies during the aging process, it can
be explained such that the high testosterone levels in
BM36301-fed males mediated the maintenance of muscle
and weight control over time. In females, feeding BM36301
lowered serum TNF-α significantly, a consequence which
may be related with healthier skin [21, 38]. It is not clear
why BM36301 conferred such gender-dependent benefits
in these distinctive health categories, but gender is indeed
known to have profound effects on skin health, immune
system, and disease [43]. Moreover, it has been reported
frequently that host gender is a crucial determinant of pro-
biotic effects. For example, an application of the L. reuteri
ATCC PTA 6475 on mice has elicited gender-dependent
responses in TNF-α suppression and bone density [44].
More comprehensive studies with various other lactobacilli
have also supported gender-dependent outcomes [45]. Like-
wise, it is possible that BM36301 affects male and female
bona fide in different ways [21, 43].
It should also be noted, however, that some observa-
tions from the BM36301 treatment were barely distin-
guishable from those of the control. For example, the
diameter of seminiferous tubules in the control male
testes was not significantly different from that of the
treatment group. Also, hairs of the control females were
as shiny as those of the BM36301-fed females. Likewise,
skin depth measurements were not very different be-
tween the two groups. Furthermore, we detected rela-
tively high populations of active hair follicle stages
(anagen + catagen) in the control. Collectively, these
dimensions suggest that the control mice were not
experiencing serious health deteriorations at the time of
observation. It is necessary to further compare any varia-
tions among the testes of male groups by examining
microscopic details, such as Leydig cells or spermato-
genesis. As a comparison, Erdman and her colleagues
reported that the L. reuteri ATCC PTA 6475 presented
skin health benefits to both male and female mice, even
though females showed more obvious fur luster than
males. In notable contrast, they observed that the con-
trol mice displayed dull fur and skin dermatitis at the
age of 40 weeks [38]. However, we did not observe such
skin deterioration in our control groups. Taken together,
we speculate that only highly elevated measures (such as
testosterone and testes in males, and TNF-α, hair re-
growth, and folliculogenesis in females) might have been
scored with significant differences in our experiments.
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These gender-dependent effects of BM36301 requires
further studies with older mice.
An increasing number of reports claim that there are
inflammation-mediated connections between gut mi-
crobes and disease [12, 19–21, 46]. That TNF-α has
been evidenced to be involved in numerous inflamma-
tory diseases prompted us to choose the cytokine as a
biomarker throughout the study [47]. However, the in-
flammatory network is very complex and many other
measurements should be additionally included for a
more comprehensive understanding. Therefore, compar-
ing the levels of a larger selection of cytokines together,
such as IL-10, IL-12, and TNF-α, may provide further
clarity upon host inflammatory status [13]. Also, direct
assessment of TH17 cells and TReg cells upon probiotic
treatments may reveal a better inflammatory rank. Fi-
nally, utilizing knockout mice of specific cytokines such
as IL-10 or IL-17, would clarify the roles of such inter-
vening molecules in the mechanism of conveying those
probiotic benefits from the gut to the immune network.
Because the pro-inflammatory TH17 cells preferentially
accumulate in the intestine, it has been postulated that
the development of TH17 cells is regulated mainly by
gut microbes [19, 20]. Therefore, anti-inflammatory
probiotics may present health benefits through IL-10-
dependent induction of the adaptive immune activities
such as CD4+CD25+Foxp3+ TReg cells, which in turn
operate to downregulate IL-17 production from TH17
cells [1, 13, 19, 21, 36, 41]. Thus it is of relative interest
to study how the probiotic BM36301 can modulate these
subsets of lymphocytes and cytokines in vivo.
Conclusion
In summary, we introduce a new human-derived strain, L.
reuteri BM36301, which shows preliminary evidence for
anti-inflammatory activities both in vitro and in vivo. The
in vitro screening method to select bacteria by CM in
combination with live cell treatments seems to be a valid
starting point for further studies toward animal applica-
tions. Current data suggest that BM36301 may fall into a
category of probiotics, which confers distinct health bene-
fits to its host in a gender-dependent manner.
Methods
Bacterial cultures, human cell lines, media, and chemicals
We isolated all the LAB used in this study from human
feces (Table 1). The lactobacilli were cultivated in
deMan, Rogosa, Sharpe (MRS; 3 M Health Care, St.
Paul, MN) media and the bifidobacterium was in BL
media (Acumedia, Lansing, MI). Anaerobic conditions
were generated with sachets of AnaeroPack-Anaero
(Mitsubishi Gas Chemical, Japan) in an air-tight jar. At
24 h of cultivation in liquid media, the L. reuteri BM36301
and BM36304 reached 1.3 × 109 colony forming units per
1 ml (CFU/ml), L. gasseri BM33601 to 2 × 108 CFU/ml,
and B. animalis subsp. lactis BM10307 to 1 × 109 CFU/ml.
The physical cell count of the L. reuteri strains, measured
on a Hemacytometer, was about 1.1 × 109/ml from this
routine, indicating that most of the cells were intact
enough to be able to produce colonies. The Escherichia
coli strains of DH10b and DH5Α were grown in Luria-
Bertani (LB) medium. The human cell lines THP-1
(TIB-202) and HT-29 (HTB-38) were purchased from
ATCC (Manassas, VA), and maintained at 37 °C under 5 %
CO2 in RPMI-1640 medium (ATCC) and in McCoy’s 5A
modified medium (Life Technologies, Carlsbad, CA), re-
spectively. These media were supplemented with 10 % fetal
bovine serum and 100 U/ml penicillin plus streptomycin
(Life Technologies). Oxgall powder was purchased from
Chem-Impex Int’l (Wood Dale, IL). The Gram staining kit
was from Fisher Scientific (Pittsburg, PA). The LPS of E.
coli 0127:B8 was obtained from Sigma (St. Louis, MO).
Characterization of probiotic properties
Classification
The taxonomic classification was confirmed by sequen-
cing the 16S rRNA and running the EZ-taxon [48] or
BLAST program against public databases.
Acid and bile resistance
Resistance tests against acid or bile salt were performed
by incubating exponentially growing bacterial cultures for
1 h at 37 °C in MRS media, with pH 2.5 for the acid chal-
lenge and MRS media containing 0.3 % Oxgall for the bile
challenge, followed by plating after serial dilutions. Con-
trol cultures without these treatments were processed in
parallel to calculate the survival rates.
Antimicrobial activity
Spots of 5 mm size in diameter with 1–2 × 105 CFU inocu-
lation from each strain were grown on MRS agar-plates for
1–2 days, followed by pouring LB soft agar containing E.
coli cells. Clear inhibitory zones were measured from the
edge of the LAB spots.
Adhesion assay
Adhesion assay was performed according to Bernet et al
with modification [16]. In brief, HT-29 cells were seeded
onto tissue culture coverslips (Sarstedt, Newton, NC)
and incubated for 15–20 days with media changes on
alternating days. Overnight-grown bacterial cultures of
1–5 × 108 CFU were applied on the coverslip for 1 h at
37 °C and 5 % CO2. After washing them five times with
phosphate buffered saline (PBS, pH 7.4), adherent bac-
teria were fixed with methanol and visualized by Gram
staining. The bacterial cells from 20 random microscopic
views were counted and the procedure was repeated
Lee et al. BMC Microbiology  (2016) 16:69 Page 10 of 13
more than three times. The average adherent bacterial
counts per HT-29 cell were shown.
Measurement of TNF-α from THP-1 cells treated with CM
or live cells
For the preparation of the CM, LAB cells were grown in
glucose-based media such as MRS or BL to the stationary
phase (up to 24 h) in a standing culture at 37 °C. Cells
were cleared by spinning at 4000 × g for 10 min. The
supernatant collected was filter-sterilized (0.2 μm, Corn-
ing, NY), vacuum-dried, and resuspended in an equal vol-
ume of RPMI-1640 [23]. The THP-1 cells of 5 × 104 in
1 ml of culture volume were stimulated with 150 ng/ml of
E. coli LPS for 3.5 h at 37 °C with 5 % CO2. The CM was
added to 5 % (v/v) prior to the LPS addition when needed.
Cultures were collected and the supernatant was used to
measure TNF-α quantitatively by ELISA method accord-
ing to the manufacturer’s instruction (Ready-Set-Go kit,
eBioscience, San Diego, CA). For physicochemical stabil-
ity, the CMs were boiled for 10 min or treated with trypsin
(0.25 mg/ml) for 30 min at 37 °C. For the live cell treat-
ment, LAB cells were grown exponentially for 16 h, col-
lected as above, washed once with PBS, and applied to
6 × 105 THP-1 cells in 250-fold excess [31]. After 6 h of
incubation at 37 °C with 5 % CO2, the cultures were col-




Eighteen week old specific pathogen-free C57BL/6 mice
were acquired from The Jackson Laboratory (Bar Harbor,
ME) and housed in a facility accredited by the Association
for Assessment and Accreditation of Laboratory Animal
Care (AAALAC), International. A total of 24 female and
18 male mice were housed in socially compatible groups
in individually ventilated cages. Mice were fed ad libitum
Teklad Global 14 % Protein Rodent Maintenance Diet
(Teklad, Madison, WI). The room in which the mice were
kept was maintained under at a 12:12 light: dark cycle.
The mice were acclimated to these conditions for 2 weeks
prior to beginning experimental use. All studies were
approved by the University of Notre Dame Institutional
Animal Care and Use Committee.
Treatment groups
At 20 weeks of age, the mice cages were randomly
placed into three treatment groups (6 males and 8
females per group) for control, BM36301, and BM36304.
The mice were closely monitored to establish that they
consumed normal volumes of water. They were weighed
every week.
Probiotic preparations
Lyophilized preparations of BM36301 and BM36304
were added to water bottles containing 250 ml of re-
versed osmosic (RO) water. Preparations were readily
reconstituted and the fresh water bottles were supplied
every day to the mice cages as a source of drinking
water. The control group mice received only RO water
with dextrose, the cryoptotectant. The amount of bac-
teria to be used was adjusted for the reconstituted water
supply so that each mouse can consume about 1 × 106
live bacteria daily for 20 weeks. The viable bacterial
counts were verified during the course at times.
Assessment of hair coat
To evaluate the effect of bacterial treatment on the
hair coat, the hair luster and hair regrowth were
assessed at times. To evaluate hair regrowth, a 2 ×
2 cm area of hair was shaved from the dorsum of the
mice after 18 weeks of LAB treatment. The hair luster
of each mouse was measured at the 19th week of LAB
treatment in a dark room with no outside light con-
tamination. The light source consisted of one 50-watt
halogen bulb delivering 430 lumens. The light meter
was a Sekonic Flashmate (model L-308S) with a Lumi-
disc sensor installed for capturing the light only dir-
ectly reflected into the detector, thereby eliminating
contamination from the light source. The ISO of the
Flashmate was set to 100. We fabricated a base and
supports to maintain consistent distance, light source
angle, and detector angle.
Euthanasia and collection of serum
Twenty weeks after initiation of treatment (40 weeks of
age), the mice were euthanized by exsanguination while
under deep carbon dioxide narcosis. Blood was sampled
by percutaneous cardiac puncture and the serum was
separated by centrifugation. To ensure death of the ani-
mals, bilateral pneumothorax was performed.
Necropsy and histopathology
Following euthanasia, necropsy was performed on
each mouse to identify any gross abnormalities. Sam-
ples of skin from the area that had been shaved from
each mouse were placed in both 10 % neutral buffered
formalin (NBF) and liquid nitrogen. Testicles were
weighed in pairs from each mouse and placed in NBF.
Formalin-fixed tissues were sectioned at 3–5 μm and
stained with Hematoxylin and Eosin in preparation for
histological examination. Skin samples were evaluated
microscopically for depth of the epidermis to the pan-
niculus carnosus. The fields chosen for measuring skin
thickness were qualified by the angle of the section;
that is, any section that was not an even cut through
the entirety of the tissue and where the thickness of
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the panniculus carnosus was not similar throughout,
was disqualified from inclusion. For each mouse, five
measurements were taken. In addition, the number of
hair follicles were counted with a minimum of five
representative high-power fields per sample. Hair fol-
licle staging was performed in a minimum of 30
longitudinally-oriented hair follicles per experimental
group. Follicles were staged for H & E stained sections
using the morphological criteria as previously de-
scribed [49]. Testicles were examined microscopically
and the diameters of ten cross-sections of seminifer-
ous tubules were measured for each mouse. Tissue
blocks were oriented to have most of the seminiferous
tubules presented in cross section. Diameters of tu-
bules were measured across the minor of their pro-
files (Additional file 1). All the pictures were taken
with a SPOT RT digital camera (software v3.5)
mounted on the Zeiss Axioplan microscope.
Measurement of serum cytokines, testosterone, and insulin
The TNF-α and IL-10 levels from the mouse serum were
measured with the mouse TNF-α high sensitivity ELISA kit
and the mouse IL-10 platinum ELISA kit, respectively
(eBioscience). Insulin was quantified with the ultra-sensitive
mouse insulin ELISA kit (Crystal Chem Inc., Downers
Grove, IL). Serum testosterone was measured with the
ELISA kit from Enzo Life Science (Farmingdale, NY).
Statistical analysis
Pairwise comparisons from multiple mouse data were
performed by the Tukey test of one-way ANOVA
method using the GraphPad Prism 6 program (Graph-
Pad Software, San Diego, CA). Two data set comparison
was confirmed by student t-test using the Excel program
(Microsoft, Richmond, WA). Any p values smaller than
0.05 were considered statistically meaningful.
Ethics approval and consent to participate
Mice were housed in a facility accredited by the Associ-
ation for Assessment and Accreditation of Laboratory
Animal Care International, and all related studies were
approved by the University of Notre Dame Institutional
Animal Care and Use Committee. The donor of the fecal
samples which were analyzed in the study has provided
consent to use the contents of the samples and their iso-
lates for the purposes of this paper.
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